Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
ds-3201b enhancer of zeste homolog 1 NA Clinical trial target TTD Carcinoma
Transitional Cell[MeSHID:D002295]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
T-Cell[MeSHID:D015458]
Myelocytic
Acute[MeSHID:D015470]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Renal Cell Carcinoma[MeSHID:D002292]
Small cell carcinoma of lung[MeSHID:D055752]		 NA phase 2 unknown
ds-3201b enhancer of zeste homolog 2 NA Successful target TTD Carcinoma
Transitional Cell[MeSHID:D002295]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
T-Cell[MeSHID:D015458]
Myelocytic
Acute[MeSHID:D015470]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Renal Cell Carcinoma[MeSHID:D002292]
Small cell carcinoma of lung[MeSHID:D055752]		 NA phase 2 unknown
click here to return to the previous page